Glutathione-disulfide reductase
Glutaricaciduria I (also known as Glutaric Acidemia Type I) is a rare genetic disorder characterized by the body's inability to fully break down certain amino acids in proteins. This condition is an inborn error of metabolism, specifically affecting the metabolism of the amino acids lysine, hydroxylysine, and tryptophan.
Etiology[edit | edit source]
Glutaricaciduria I is caused by mutations in the GCDH gene, which provides instructions for producing an enzyme called glutaryl-CoA dehydrogenase. This enzyme plays a crucial role in breaking down lysine, hydroxylysine, and tryptophan. Mutations in the GCDH gene reduce or eliminate the activity of this enzyme, preventing these amino acids from being metabolized properly. As a result, harmful amounts of glutaric acid and related compounds build up in the body, causing damage to the brain and other organs.
Symptoms[edit | edit source]
The symptoms of Glutaricaciduria I can vary widely among affected individuals. They typically appear in infancy or early childhood and can include developmental delay, muscle weakness, and movement problems. Some individuals may also have an unusually large head size (macrocephaly) and other physical abnormalities.
Diagnosis and Treatment[edit | edit source]
Diagnosis of Glutaricaciduria I typically involves genetic testing to identify mutations in the GCDH gene. Treatment is primarily focused on managing symptoms and preventing complications. This may involve dietary restrictions to limit intake of the affected amino acids, medications to help remove excess glutaric acid from the body, and physical therapy to help manage movement problems.
Prognosis[edit | edit source]
The prognosis for individuals with Glutaricaciduria I can vary widely, depending on the severity of symptoms and the effectiveness of treatment. With early diagnosis and appropriate management, many individuals with this condition can lead relatively normal lives.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Glutathione-disulfide reductase is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD